Craneware's (CRW) Buy Rating Reaffirmed at UBS Group

Key Points

• UBS Group reiterated a Buy rating on Craneware but set a surprisingly low price target of GBX 570, implying about a 57.3% downside from the current share price.
• Other analysts remain bullish: four analysts have a Buy consensus with an average target of GBX 2,297.75, and Berenberg and Shore Capital recently set targets at GBX 2,900 and GBX 2,850, respectively.
• Craneware shares opened at GBX 1,335; the company has a market cap of £474.05 million, a trailing P/E of 24.18, and a one‑year trading range of GBX 1,290–2,644.

Craneware (LON:CRW - Get Free Report)'s stock had its "buy" rating reiterated by equities research analysts at UBS Group in a research note issued on Wednesday, Marketbeat Ratings reports. They presently have a GBX 570 price target on the stock. UBS Group's target price points to a potential downside of 57.30% from the company's current price.

CRW has been the topic of a number of other reports. Berenberg Bank reaffirmed a "buy" rating and issued a GBX 2,900 price objective on shares of Craneware in a research note on Tuesday, January 20th. Shore Capital Group reissued a "buy" rating and issued a GBX 2,850 price target on shares of Craneware in a research note on Tuesday, January 20th. Four analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Craneware has a consensus rating of "Buy" and an average target price of GBX 2,297.75.

Craneware Stock Up 1.5%

Shares of LON:CRW opened at GBX 1,335 on Wednesday. The company has a debt-to-equity ratio of 7.93, a current ratio of 0.76 and a quick ratio of 1.00. The stock has a market cap of £474.05 million, a price-to-earnings ratio of 24.18 and a beta of 0.28. The company has a 50 day moving average of GBX 1,560.64 and a 200-day moving average of GBX 1,945.37. Craneware has a one year low of GBX 1,290 and a one year high of GBX 2,644.

About Craneware

For over 25 years, The Craneware Group AIM: CRW.L has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster - that simplify the complexities of healthcare finance and operations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.